|
COPYRIGHT 2006 International Medical News Group
Most patients with diabetic peripheral neuropathic pain will experience significant relief and improved quality of life when treated with tricyclic antidepressants, duloxetine, controlled-release oxycodone, pregabalin, or a combination of these agents, according to new treatment guidelines issued by the American Society of Pain Educators.
Treatment strategies should begin with these drugs, which have already been proven effective in the disorder, and take into account physical and psychiatric comorbidities (see box), adverse event profiles, and cost, according to the guidelines (Mayo Clin. Proc. 2006;81[4 Suppl]:S12-25).
Almost all patients with diabetic peripheral neuropathic pain (DPNP) will improve if they and their physicians are...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
